Is Abbott Laboratories (ABT) a Buy, Sell, or Hold?
NYSE : ABT
Abbott Laboratories — Stock Grades
$107.32 USD
$2.83 (2.71%)
- Volume
- 10.18M
- Average Volume
- 13.4M
- Market Capitalization
- $186.93B
- P/E Ratio
- 34.51
- Dividend Yield
- 2.31%
- Price Target
- $120.00
- Year High
- $137.49
- Year Low
- $81.97
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.79
- Current Ratio
- $1.38
ABT Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-17 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-07-17 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-07-17 | Citigroup | Buy | Buy | Maintain |
| 2026-07-17 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-07-17 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-07-17 | TD Cowen | Buy | Buy | Maintain |
| 2026-07-17 | BTIG | Buy | Buy | Maintain |
| 2026-07-17 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-07-06 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-06-22 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-04-27 | BTIG | Buy | Buy | Maintain |
| 2026-04-20 | Barclays | Overweight | Overweight | Maintain |
| 2026-04-17 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-04-17 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-04-17 | BTIG | Buy | Buy | Maintain |
| 2026-04-17 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-17 | Benchmark | Buy | Buy | Maintain |
| 2026-04-17 | B of A Securities | Buy | Buy | Maintain |
| 2026-04-17 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-04-17 | Stifel | Buy | Buy | Maintain |
| 2026-04-09 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-04-08 | Barclays | Overweight | Overweight | Maintain |
| 2026-04-06 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-03-31 | BTIG | Buy | Buy | Maintain |
| 2026-03-26 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-03-11 | Citigroup | Buy | Buy | Maintain |
| 2026-02-02 | Barclays | Overweight | Overweight | Maintain |
| 2026-01-29 | Freedom Broker | Hold | Buy | Upgrade |
| 2026-01-23 | Bernstein | Outperform | Outperform | Maintain |
| 2026-01-23 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-01-23 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-01-23 | Citigroup | Buy | Buy | Maintain |
| 2026-01-23 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-01-23 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-01-23 | BTIG | Buy | Buy | Maintain |
| 2026-01-23 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-09 | Bernstein | Outperform | Outperform | Maintain |
| 2026-01-05 | Barclays | Overweight | Overweight | Maintain |